Chemicals and Drugs

Alendronate

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

Synonyms

8 entry terms
  • 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate
  • Aminohydroxybutane Bisphosphonate
  • Alendronate Monosodium Salt, Trihydrate
  • Alendronate Sodium
  • Fosamax
  • MK-217
  • MK 217
  • MK217

MeSH Record

Aspects Covered

25 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

1997 (1987)

MeSH Record

Previous Indexing

  • Diphosphonates (1987-1996)

MeSH Hierarchy

Tree Number

  1. D02w.705w.429.500w.100w

AMA Style

References

  1. National Library of Medicine. Alendronate. Medical Subject Headings (MeSH). 2026. Unique ID D019386. http://id.nlm.nih.gov/mesh/2026/D019386
  2. Alendronate. In: Wikipedia. https://en.wikipedia.org/wiki/Alendronic_acid
  3. Alendronate. In: Wikidata. https://www.wikidata.org/wiki/Q420057